Navigation Links
DePuy Announces It Will Stop Selling Metal-On-Metal Hip Implants, Notes Rottenstein Law Group LLP

(PRWEB) May 17, 2013

Johnson & Johnson subsidiary DePuy Orthopaedics announced on May 16 that it will stop sales of metal-on-metal hip replacements. This comes after the company saw the market for the products drop significantly* amid lawsuits and calls for increased regulation,** and after the 2010 recall of the DePuy ASR hip implant. The Rottenstein Law Group LLP, a metal-on-metal hip implant law firm, applauds the decision to remove these products from the market and notes that it maintains a comprehensive website at with information on the metal-on-metal hip products from a variety of companies facing increased scrutiny.

Johnson & Johnson said its decision to stop selling the metal liners in the Ultamet Metal-on-Metal Articulation and Complete Ceramic-on-Metal Acetabular Hip System was because of decreased demand and not because of the safety concerns cited by the FDA regarding metal-on-metal hips or the more than 10,000 lawsuits pending against DePuy over the ASR hip implant system (In re: DePuy Orthopaedics Inc., ASR Hip Implant Products Liability Litigation, MDL-2197 (U.S. District Court for the Northern District of Ohio)), according to a May 16 Bloomberg report. The company will continue to sell its DePuy Pinnacle system, though.

“Although the company has said that it did not make this marketing decision because of lawsuits or regulations, the fact remains that there is a recent marked increase of scrutiny of metal-on-metal hips,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP.

For those who believe their metal-on-metal hip implant has injured them, the Rottenstein Law Group LLP offers an in-depth look at hip replacement settlements for metal-on-metal hip implants manufactured by DePuy, Stryker, Smith & Nephew, Biomet and Wright Medical. Common alleged side effects the firm hears about include metallosis (metal poisoning) and the need for revision surgery. The first trial in the country in Los Angeles resulted in the plaintiff winning an $8.3 million damages award (Kransky v. DePuy; BC456086, Los Angeles Superior Court).

For the latest news on defective medications and medical devices and related lawsuits, visit the Rottenstein Law Group LLP’s Injury Lawyer Newswire at Readers can subscribe to the news site’s stories and videos to stay on top of personal injury news.


The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com


Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products
2. DePuy Pinnacle Hip Implant Lawsuit News: Bernstein Liebhard LLP Comments on Johnson & Johnson Decision to Stop Metal-on-Metal Hip Sales
3. DePuy ASR Lawsuit Update: Rottenstein Law Group Comments on Delay of Second Federal Trial
4. DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Rescheduling of First Bellwether Trial in Federal DePuy ASR Litigation
5. Alleged DePuy Knee Sleeve Failure Lawsuits Now Being Reviewed by Resource4thePeople Attorneys
6. DePuy ASR Lawsuit Update: Rottenstein Law Group Addresses J&J Motion to Appeal $8.3 Million Verdict
7. DePuy ASR Hip Replacement Lawsuits: Bernstein Liebhard LLP Notes Upcoming Conference in New Jersey DePuy ASR Hip Recall Litigation
8. California Jury Awards Man $8 Million after Injured by Defective DePuy ASR Hip Implant
9. DrugRisk Announces Launch of DePuy Hip Resource Center
10. Ongoing Litigation Over Failed DePuy and Stryker Hip Implants Continue Driving Traffic to Number One Website for Cobalt Chromium Toxicity Information
11. Compensation Justified in DePuy ASR $8.35 Million Verdict
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television series, "Voices in America", ... delves into an array of issues that are presently affecting Americans. Dedicated to providing ... this show is changing the subjects consumers focus on, one episode at a time. ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... successful and prominent nonprofit healthcare organizations in the country. They have overseen financial ... organizations, and helped advance the healthcare industry as a whole through their advocacy ...
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at Serenity Point ... come together on Thanksgiving Day to share the things that they are most ... Serenity Point YouTube channel, patients displayed what they wrote on index cards, describing ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent ... and the need to integrate dose form selection in early phase drug development. ... membership organization supporting and bringing together the UK’s emerging life sciences companies, corporate ...
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel Film Studios brings ... with ProTrailer: Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired ... font, giving users limitless opportunities to stylize and create designs quickly and easily, ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... DUBLIN , Nov. 26, 2015 /PRNewswire/ ... announced the addition of the "2016 ... by Test, Country Volume and Sales Segment ... Emerging Opportunities" report to their offering. ... the addition of the "2016 Global ...
(Date:11/26/2015)... --> --> ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... with Bremachlorin-photodynamic therapy for advanced cancer.   ... with Bremachlorin-photodynamic therapy for advanced cancer.   ... immunotherapy can be efficiently combined with photodynamic therapy (PDT) ...
(Date:11/26/2015)... FRANCISCO , November 26, 2015 ... billion by 2022, according to a new report by Grand ... Chronic Kidney Disease (CKD) which demands kidney transplantation is expected ... and cost effective substitute for organ transplantation. --> ... billion by 2022, according to a new report by Grand ...
Breaking Medicine Technology: